Cita APA (7a ed.)
Dejaco, C., Mueller, T., Zamani, O., Kurtz, U., Egger, S., Resch-Passini, J., . . . Rickert, V. (Jun 2018). FRI0108 Golimumab improves work productivity and activity and quality of life in patients with rheumatoid arthritis (RA), psoriasis arthritis (PSA) and axial spondyloarthritis (AXSPA): Interim results from a non-interventional study in austria (go active). Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2018-eular.2411
Cita Chicago Style (17a ed.)
Dejaco, C., et al. "FRI0108 Golimumab Improves Work Productivity and Activity and Quality of Life in Patients with Rheumatoid Arthritis (RA), Psoriasis Arthritis (PSA) and Axial Spondyloarthritis (AXSPA): Interim Results from a Non-interventional Study in Austria (go Active)." Annals of the Rheumatic Diseases Jun 2018. https://doi.org/10.1136/annrheumdis-2018-eular.2411.
Cita MLA (9a ed.)
Dejaco, C., et al. "FRI0108 Golimumab Improves Work Productivity and Activity and Quality of Life in Patients with Rheumatoid Arthritis (RA), Psoriasis Arthritis (PSA) and Axial Spondyloarthritis (AXSPA): Interim Results from a Non-interventional Study in Austria (go Active)." Annals of the Rheumatic Diseases, Jun 2018, https://doi.org/10.1136/annrheumdis-2018-eular.2411.
Precaución: Estas citas no son 100% exactas.